| Disparities in survival by insurance status in follicular lymphoma JS Goldstein, LJ Nastoupil, X Han, A Jemal, E Ward, CR Flowers Blood, The Journal of the American Society of Hematology 132 (11), 1159-1166, 2018 | 28 | 2018 |
| Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma RA Harkins, A Chang, SP Patel, MJ Lee, JS Goldstein, S Merdan, ... Expert review of hematology 12 (11), 959-973, 2019 | 26 | 2019 |
| PET-derived tumor metrics predict DLBCL response and progression-free survival P Islam, J Goldstein, CR Flowers Leukemia & lymphoma, 2019 | 23 | 2019 |
| Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase study AJ Ritter, JS Goldstein, AA Ayers, CR Flowers Leukemia & lymphoma 60 (7), 1656-1667, 2019 | 21 | 2019 |
| A population‐based multistate model for diffuse large B‐cell lymphoma–specific mortality in older patients Ç Çağlayan, JS Goldstein, T Ayer, A Rai, CR Flowers Cancer 125 (11), 1837-1847, 2019 | 17 | 2019 |
| Insurance status impacts overall survival in Burkitt lymphoma JS Goldstein, JM Switchenko, M Behera, CR Flowers, JL Koff Leukemia & lymphoma 60 (13), 3225-3234, 2019 | 12 | 2019 |
| Novel agents in relapsed/refractory diffuse large B‐cell lymphoma G Varma, J Goldstein, RH Advani Hematological Oncology 41, 92-106, 2023 | 7 | 2023 |
| Assessing the effectiveness of treatment sequences for older patients with high-risk follicular lymphoma with a multistate model Ç Çağlayan, H Terawaki, T Ayer, JS Goldstein, A Rai, Q Chen, C Flowers Clinical Lymphoma Myeloma and Leukemia 19 (5), 300-309. e5, 2019 | 7 | 2019 |
| Utilizing digital pathology informatics algorithms for diffuse large B-cell lymphoma subtyping JS Goldstein, S Lee, J Jordan, DL Jaye, C Flowers, L Cooper Blood 130, 4147, 2017 | 5 | 2017 |
| Association of insurance status and race with overall survival among patients with cutaneous T-cell lymphoma: A National Cancer DataBase analysis. PB Allen, C Flowers, MJ Lechowicz, J Goldstein Journal of Clinical Oncology 36 (15_suppl), e18624-e18624, 2018 | 4 | 2018 |
| Informatics approaches to address new challenges in the classification of lymphoid malignancies J Jordan, JS Goldstein, DL Jaye, M Gurcan, CR Flowers, LAD Cooper JCO clinical cancer informatics 2, 1-9, 2018 | 4 | 2018 |
| Ultrasensitive circulating tumor DNA (ctDNA) minimal residual disease (MRD) detection in early stage non-small cell lung cancer (NSCLC). JM Isbell, JS Goldstein, EG Hamilton, SY Liu, J Eichholz, DJ Buonocore, ... Journal of Clinical Oncology 42 (16_suppl), 8078-8078, 2024 | 2 | 2024 |
| PET-derived tumor metrics predict DLBCL response and progression-free survival P Islam, JS Goldstein, I Sethi, D Lee, C Flowers Blood 130, 4140, 2017 | 2 | 2017 |
| Mathematical modeling of ctDNA dynamics to predict utility of ultrasensitive MRD assays in early stage non-small cell lung cancer (NSCLC) JS Goldstein, C Abbosh, AA Alizadeh, M Diehn, DM Kurtz Cancer Research 84 (6_Supplement), 986-986, 2024 | 1 | 2024 |
| Optimizing Circulating Tumor DNA Limits of Detection for DLBCL during First Line Therapy J Goldstein, WS Kim, SE Yoon, SJ Kim, M Roschewski, J Westin, ... Blood 142, 187, 2023 | 1 | 2023 |
| Overall survival disparities in metro/urban/rural diffuse large B-cell lymphoma (DLBCL) patients AJ Ritter, JS Goldstein, AT Phan, C Flowers Blood 130, 4159, 2017 | 1 | 2017 |
| ViPOR’s Venom—Rationally Targeting DLBCL with Precision JS Goldstein, AA Alizadeh New England Journal of Medicine 390 (23), 2209-2211, 2024 | | 2024 |
| Evaluation of the prognostic utility of bone marrow biopsy in diffuse large B-Cell lymphoma in the SEER-Medicare dataset D Luan, Y Wu, J Goldstein, S Rutherford, JP Leonard, P Martin Leukemia & Lymphoma 62 (8), 1850-1859, 2021 | | 2021 |
| Evaluation of the Prognostic Utility of Bone Marrow Biopsy in Diffuse Large B-Cell Lymphoma: A SEER-Medicare Linked Database Analysis D Luan, Y Wu, JS Goldstein, SC Rutherford, JP Leonard, P Martin Blood 136, 10-11, 2020 | | 2020 |
| A Multi-State Model for Follicular Lymphoma in Patients with Early Progression to Second Line Therapy C Caglayan, H Terawaki, T Ayer, JS Goldstein, A Rai, Q Chen, C Flowers Blood 130, 2187, 2017 | | 2017 |
